The estimated Net Worth of Harry E Gruber is at least $680 Tysiąc dollars as of 24 May 2019. Harry Gruber owns over 5,000 units of Tocagen stock worth over $680,131 and over the last 7 years Harry sold TOCA stock worth over $0.
Sign up
Harry Gruber TOCA stock SEC Form 4 insiders trading
Harry has made over 2 trades of the Tocagen stock since 2017, according to the Form 4 filled with the SEC. Most recently Harry bought 5,000 units of TOCA stock worth $22,800 on 24 May 2019.
The largest trade Harry's ever made was buying 25,000 units of Tocagen stock on 19 April 2017 worth over $250,000. On average, Harry trades about 4,286 units every 109 days since 2017. As of 24 May 2019 Harry still owns at least 9,744 units of Tocagen stock.
You can see the complete history of Harry Gruber stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Harry Gruber's mailing address?
Harry's mailing address filed with the SEC is 3030 Bunker Hill St #230, San Diego, CA 92109, USA.
Insiders trading at Tocagen
Over the last 7 years, insiders at Tocagen have traded over $0 worth of Tocagen stock and bought 339,950 units worth $1,867,749 . The most active insiders traders include Faheem Hasnain, Steven Michael Oliveira oraz Franklin M Berger. On average, Tocagen executives and independent directors trade stock every 99 days with the average trade being worth of $2,157,169. The most recent stock trade was executed by Steven Michael Oliveira on 14 April 2020, trading 74,301 units of TOCA stock currently worth $88,418.
What does Tocagen do?
Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer. It is in the business of discovery, development, and commercialization of products for the treatment of cancer. The company was founded by Thomas E. Darcy, Harry E. Gruber, Douglas J. Jolly, and Dennis N. Berman in August 2007 and is headquartered San Diego, CA.
What does Tocagen's logo look like?
Complete history of Harry Gruber stock trades at Tocagen
Tocagen executives and stock owners
Tocagen executives and other stock owners filed with the SEC include:
-
Fairooz Kabbinavar,
Senior Vice President, Clinical Development -
Thomas Darcy,
Director -
Peter Rahmer,
IR Contact Officer -
Donald Williams,
Director -
Patricia Walker,
Director -
Steven Kornfeld,
Director -
Lawrence Eichenfield,
Director -
Antony Riley,
Chief Financial Officer -
Paul Wagner,
Chairman of the Board, President, Chief Executive Officer -
Steven Michael Oliveira,
10% owner -
Asha Das,
SVP & Chief Medical Officer -
Franklin M Berger,
Director -
Paul Schimmel,
Director -
Dennis N Berman,
-
Harry E Gruber,
President, Science&Innovation -
Douglas Jolly,
EVP, Research & Pharm Devel -
Martin J Duvall,
Chief Executive Officer -
Faheem Hasnain,
Director -
Mark G Foletta,
EVP & Chief Financial Officer -
David Ross Parkinson,
Director -
Lori Anne Kunkel,
Director